Andrea S. James, Chief Financial Officer at Oncocyte Corp (OCX), bought 20,000 shares at $2.29 ($46K) on 2024-12-05, disclosed to the SEC on 2024-12-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |